Investing In Stem Cell Science

Wired notes that restrictive legislation, politics and controversy have scared away venture capital from investing in stem cell research. Private for-profit investors are notoriously risk-averse, and the present polical environment makes stem cell investment look like a very risky bet. "But while they may not be investing in the companies themselves, venture capitalists haven't completely abandoned stem-cell work. Instead, they're contributing through efforts like the California Stem Cell Initiative. If the initiative passes in November, the political climate for embryonic stem-cell research will likely be more agreeable, at least in California."



Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.